Riskpilot← Back to searchSign inGet full accessSAFE STERILIZATION A/S
A/SActiveCVR 33641907Godtfreds Høje 6All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20113 employeeswww.safeint.com
Revenue 2025
DKK 3,9M
+2% vs 2024
EBITDA margin
55.7%
+22% vs 2024
Equity ratio
48.8%
Financial strength
Net profit 2025
DKK 1,8M
+20% vs 2024
| Revenue | DKK 3,9M | +2% |
| EBITDA | DKK 2,2M | +22% |
| Net profit | DKK 1,8M | +20% |
| Total assets | DKK 6,8M | +6% |
| Equity | DKK 3,3M | +10% |
| Employees | 3 | — |
Legal name
SAFE STERILIZATION A/S
CVR number
33641907
Legal form
Aktieselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
2. maj 2011
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør
Company purpose
Selskabets formål er at drive handels- og servicevirksomhed
Address
Godtfreds Høje 6
Phone
+4570231313
Email
toch@safeint.com
Website
www.safeint.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.637 | 3.821 | 3.120 | 2.907 | 3.453 | 3.344 | 3.485 | 2.346 | 3.069 | 3.037 | 3.184 | 4.072 | 3.804 | 3.890 |
| Staff expenses | -1.499 | -1.390 | -1.436 | -1.647 | -1.667 | -2.023 | -2.197 | -1.064 | -1.350 | -1.683 | -1.629 | -2.203 | -2.023 | -1.724 |
| EBITDA | 1.317 | 1.379 | 1.683 | 1.260 | 1.786 | 1.322 | 1.288 | 1.282 | 1.719 | 1.354 | 1.555 | 1.869 | 1.782 | 2.166 |
| Depreciation & amort. | -436 | -466 | -442 | -450 | -441 | -454 | -188 | -69 | -129 | -132 | -136 | -136 | -153 | -73 |
| EBIT | 881 | 914 | 1.242 | 810 | 1.345 | 868 | 1.100 | 1.213 | 1.590 | 1.222 | 1.419 | 1.733 | 1.629 | 2.092 |
| Net financials | -30 | 22 | 55 | -14 | -13 | 37 | 53 | 15 | 21 | 112 | 125 | 101 | 290 | 202 |
| Profit before tax | 850 | 936 | 1.297 | 795 | 1.332 | 905 | 1.153 | 1.228 | 1.611 | 1.333 | 1.544 | 1.834 | 1.919 | 2.295 |
| Tax | 215 | 243 | 318 | 180 | 294 | 200 | 255 | 273 | 355 | 294 | 340 | 404 | 422 | 506 |
| Net profit | 635 | 693 | 979 | 615 | 1.039 | 705 | 898 | 955 | 1.257 | 1.039 | 1.204 | 1.430 | 1.497 | 1.789 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.406 | 4.374 | 5.224 | 4.895 | 4.043 | 2.794 | 3.096 | 2.559 | 4.166 | 5.726 | 7.073 | 6.553 | 6.376 | 6.753 |
| Equity | 1.219 | 1.712 | 2.090 | 2.706 | 2.694 | 1.799 | 1.997 | 1.653 | 633 | 1.672 | 2.876 | 2.907 | 3.003 | 3.292 |
| Long-term debt | 0 | 0 | 1.200 | 800 | 0 | 0 | 0 | 228 | 310 | 456 | 504 | 576 | 500 | 564 |
| Short-term debt | 3.187 | 2.662 | 1.925 | 1.389 | 1.349 | 971 | 1.051 | 565 | 3.133 | 3.531 | 3.651 | 3.054 | 2.871 | 2.890 |
| Total debt | 3.187 | 2.662 | 3.125 | 2.189 | 1.349 | 971 | 1.051 | 794 | 3.444 | 3.988 | 4.155 | 3.629 | 3.371 | 3.454 |
EBITDA margin
55.7%
This company
15.8%
Market median
+253% vs market
20122025
Equity ratio
48.8%
This company
38.2%
Market median
+28% vs market
20122025
Return on equity
54.3%
This company
18.4%
Market median
+195% vs market
20122025
Net profit margin
46.0%
This company
8.1%
Market median
+468% vs market
20122025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20122025
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TC Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
FN | Audit | 2011 | — | — |
JL Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMPROTECH HOLDING ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMPROTECH HOLDING ApS
SAFE STERILIZATION A/S Board members of SAFE STERILIZATION A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Christensen | Chief Executive Officer | 0 companies |
| Flemming Nygaard Nielsen | Audit | 0 companies |
| Jette Lykke Vedstesen | Management | 0 companies |
| Lone Askjær Hass | Chairman | 0 companies |
| Jonathan Bjerre Sanders | Board of Directors | 0 companies |